| Product Code: ETC13165007 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Oncology Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Oncology Drugs Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Oncology Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Oncology Drugs Market - Industry Life Cycle |
3.4 Africa Oncology Drugs Market - Porter's Five Forces |
3.5 Africa Oncology Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Oncology Drugs Market Revenues & Volume Share, By Therapy Modality, 2021 & 2031F |
3.7 Africa Oncology Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
4 Africa Oncology Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Oncology Drugs Market Trends |
6 Africa Oncology Drugs Market, 2021 - 2031 |
6.1 Africa Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Oncology Drugs Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.1.3 Africa Oncology Drugs Market, Revenues & Volume, By Targeted Therapy, 2021 - 2031 |
6.1.4 Africa Oncology Drugs Market, Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021 - 2031 |
6.1.5 Africa Oncology Drugs Market, Revenues & Volume, By Hormonal Therapy, 2021 - 2031 |
6.1.6 Africa Oncology Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Africa Oncology Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Oncology Drugs Market, Revenues & Volume, By Blood Cancer, 2021 - 2031 |
6.2.3 Africa Oncology Drugs Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.4 Africa Oncology Drugs Market, Revenues & Volume, By Gastrointestinal Cancer, 2021 - 2031 |
6.2.5 Africa Oncology Drugs Market, Revenues & Volume, By Respiratory/Lung Cancer, 2021 - 2031 |
6.2.6 Africa Oncology Drugs Market, Revenues & Volume, By Skin Cancer, 2021 - 2031 |
6.2.7 Africa Oncology Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa Oncology Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
7.2.1 South Africa Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
7.2.2 Egypt Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
7.2.3 Nigeria Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
7.2.4 Rest of Africa Oncology Drugs Market, Revenues & Volume, By Therapy Modality, 2021 - 2031 |
7.3 Africa Oncology Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 South Africa Oncology Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Egypt Oncology Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 Nigeria Oncology Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.4 Rest of Africa Oncology Drugs Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
8 Africa Oncology Drugs Market Key Performance Indicators |
9 Africa Oncology Drugs Market - Export/Import By Countries Assessment |
10 Africa Oncology Drugs Market - Opportunity Assessment |
10.1 Africa Oncology Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Oncology Drugs Market Opportunity Assessment, By Therapy Modality, 2021 & 2031F |
10.3 Africa Oncology Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
11 Africa Oncology Drugs Market - Competitive Landscape |
11.1 Africa Oncology Drugs Market Revenue Share, By Companies, 2022 |
11.2 Africa Oncology Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here